Elanco Animal Health (ELAN) Cash from Investing Activities (2017 - 2026)

Elanco Animal Health has reported Cash from Investing Activities for 10 years, with the latest figure at -$60.0 million in Q1 2026.

• Quarterly Cash from Investing Activities fell 3.45% year-over-year to -$60.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$281.0 million (down 126.43% YoY) and the FY2025 annual result came in at -$279.0 million, down 124.09% from the prior year.
• Cash from Investing Activities climbed to -$60.0 million in Q1 2026 per ELAN's latest filing, from -$64.0 million in the prior quarter.
• Over five years, Cash from Investing Activities peaked at $1.2 billion in Q3 2024 and troughed at -$101.0 million in Q3 2025.
• A 5-year average of $27.7 million and a median of -$43.0 million in 2023 frame the typical range for Cash from Investing Activities.
• The sharpest annual moves came in 2022 and 2024: Cash from Investing Activities slumped 390.0% in 2022, then surged 3555.56% in 2024.
• Over 5 years, Cash from Investing Activities stood at -$76.0 million in 2022, then soared by 53.95% to -$35.0 million in 2023, then slumped by 157.14% to -$90.0 million in 2024, then advanced by 28.89% to -$64.0 million in 2025, then advanced by 6.25% to -$60.0 million in 2026.
• According to Business Quant data, Cash from Investing Activities over the past three periods registered -$60.0 million, -$64.0 million, and -$101.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.